BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+11.22%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$10.3B
AUM Growth
+$10.3B
Cap. Flow
+$826M
Cap. Flow %
8.01%
Top 10 Hldgs %
81.62%
Holding
101
New
12
Increased
23
Reduced
8
Closed
11

Top Buys

1
INSM icon
Insmed
INSM
$235M
2
SMMT icon
Summit Therapeutics
SMMT
$198M
3
ALKS icon
Alkermes
ALKS
$55.1M
4
RVMD icon
Revolution Medicines
RVMD
$52.5M
5
GPCR icon
Structure Therapeutics
GPCR
$44.5M

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$22.3M
2
ARGX icon
argenx
ARGX
$22M
3
CNTA
Centessa Pharmaceuticals
CNTA
$17.6M
4
TSVT
2seventy bio
TSVT
$12.3M
5
AKRO icon
Akero Therapeutics
AKRO
$12M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IDYA icon
26
IDEAYA Biosciences
IDYA
$2.33B
$44.5M 0.43%
2,118,728
+1,056,605
+99% +$22.2M
NRIX icon
27
Nurix Therapeutics
NRIX
$728M
$44.2M 0.43%
3,882,125
– –
ROIV icon
28
Roivant Sciences
ROIV
$8.69B
$42.5M 0.41%
3,767,773
– –
BNTX icon
29
BioNTech
BNTX
$24.2B
$39.3M 0.38%
368,923
+323,892
+719% +$34.5M
TRDA icon
30
Entrada Therapeutics
TRDA
$206M
$32.7M 0.32%
4,865,819
– –
MRUS icon
31
Merus
MRUS
$5.09B
$30.2M 0.29%
574,377
+350,877
+157% +$18.5M
PRAX icon
32
Praxis Precision Medicines
PRAX
$974M
$29M 0.28%
689,488
+357,955
+108% +$15.1M
NTLA icon
33
Intellia Therapeutics
NTLA
$1.32B
$25.1M 0.24%
2,675,674
+2,031,558
+315% +$19.1M
VRDN icon
34
Viridian Therapeutics
VRDN
$1.62B
$24.4M 0.24%
+1,744,406
New +$24.4M
GLUE icon
35
Monte Rosa Therapeutics
GLUE
$313M
$22.2M 0.22%
4,916,095
– –
VRNA
36
Verona Pharma
VRNA
$9.18B
$21.2M 0.21%
223,843
– –
PCVX icon
37
Vaxcyte
PCVX
$4.15B
$20.8M 0.2%
640,885
– –
ARGX icon
38
argenx
ARGX
$43.6B
$20.8M 0.2%
37,760
-40,000
-51% -$22M
VERV
39
DELISTED
Verve Therapeutics
VERV
$19M 0.18%
1,691,530
– –
CERS icon
40
Cerus
CERS
$253M
$18.2M 0.18%
12,883,844
-6,467,243
-33% -$9.12M
IRON icon
41
Disc Medicine
IRON
$2.19B
$17.9M 0.17%
337,050
+260,000
+337% +$13.8M
AKRO icon
42
Akero Therapeutics
AKRO
$3.68B
$17.3M 0.17%
324,630
-224,083
-41% -$12M
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$16.1M 0.16%
+125,538
New +$16.1M
SERA icon
44
Sera Prognostics
SERA
$135M
$15.2M 0.15%
5,498,170
– –
ARWR icon
45
Arrowhead Research
ARWR
$3.79B
$14.8M 0.14%
+939,174
New +$14.8M
NGNE icon
46
Neurogene
NGNE
$279M
$14.8M 0.14%
991,691
-494,509
-33% -$7.39M
DNTH icon
47
Dianthus Therapeutics
DNTH
$777M
$14.7M 0.14%
+789,759
New +$14.7M
CLDX icon
48
Celldex Therapeutics
CLDX
$1.53B
$13.5M 0.13%
665,370
+417,726
+169% +$8.5M
DBVT
49
DBV Technologies
DBVT
$250M
$13.4M 0.13%
1,461,425
– –
XENE icon
50
Xenon Pharmaceuticals
XENE
$3.06B
$11.6M 0.11%
370,208
+22,800
+7% +$714K
1
2
3 4